157 related articles for article (PubMed ID: 7915618)
1. Somatostatin and the lung.
O'Byrne KJ; Carney DN
Lung Cancer; 1993 Dec; 10(3-4):151-72. PubMed ID: 7915618
[TBL] [Abstract][Full Text] [Related]
2. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
3. Characterization of somatostatin receptors and growth inhibition by the somatostatin analogue BIM23014 in small cell lung carcinoma xenograft: SCLC-6.
Prévost G; Bourgeois Y; Mormont C; Lerrant Y; Veber N; Poupon MF; Thomas F
Life Sci; 1994; 55(2):155-62. PubMed ID: 8015359
[TBL] [Abstract][Full Text] [Related]
4. [Role of somatostatin analogs in the treatment of neuroendocrine tumours].
Cuccurullo V; Cascini GL; Rambaldi PF; Mansi L
Minerva Endocrinol; 2001 Sep; 26(3):135-43. PubMed ID: 11753236
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor expression in lung cancer.
O'Byrne KJ; Halmos G; Pinski J; Groot K; Szepeshazi K; Schally AV; Carney DN
Eur J Cancer; 1994; 30A(11):1682-7. PubMed ID: 7833144
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin analogs for diagnosis and treatment of cancer.
Weckbecker G; Raulf F; Stolz B; Bruns C
Pharmacol Ther; 1993 Nov; 60(2):245-64. PubMed ID: 7912834
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin analogues and small-cell lung carcinoma.
Taylor JE
Recent Results Cancer Res; 1993; 129():71-82. PubMed ID: 8102490
[No Abstract] [Full Text] [Related]
8. Octapeptide analogues of somatostatin inhibit the clonal growth and vasoactive intestinal peptide-stimulated cyclic AMP formation in human small cell lung cancer cells.
Taylor JE; Moreau JP; Baptiste L; Moody TW
Peptides; 1991; 12(4):839-43. PubMed ID: 1686316
[TBL] [Abstract][Full Text] [Related]
9. Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours.
Van Essen M; Krenning EP; De Jong M; Valkema R; Kwekkeboom DJ
Acta Oncol; 2007; 46(6):723-34. PubMed ID: 17653893
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin, its receptors and analogs, in lung cancer.
O'Byrne KJ; Schally AV; Thomas A; Carney DN; Steward WP
Chemotherapy; 2001; 47 Suppl 2():78-108. PubMed ID: 11275704
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt.
Zatelli MC; Tagliati F; Taylor JE; Rossi R; Culler MD; degli Uberti EC
J Clin Endocrinol Metab; 2001 May; 86(5):2161-9. PubMed ID: 11344221
[TBL] [Abstract][Full Text] [Related]
12. [Detection of somatostatin receptors in tumors in the area of the head and neck and their clinical importance].
Kau RJ; Wagner-Manslau C; Saumweber DM; Arnold W
Laryngorhinootologie; 1994 Jan; 73(1):21-6. PubMed ID: 7908199
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2.
Buscail L; Delesque N; Estève JP; Saint-Laurent N; Prats H; Clerc P; Robberecht P; Bell GI; Liebow C; Schally AV
Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2315-9. PubMed ID: 7907795
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin analogs in the treatment of medullary thyroid carcinoma.
Díez JJ; Iglesias P
J Endocrinol Invest; 2002 Oct; 25(9):773-8. PubMed ID: 12398235
[TBL] [Abstract][Full Text] [Related]
15. The potential role of somatostatin analogues in breast cancer treatment.
Pollak M
Yale J Biol Med; 1997; 70(5-6):535-9. PubMed ID: 9825480
[TBL] [Abstract][Full Text] [Related]
16. Molecular pharmacology of somatostatin-receptor subtypes.
Bruns C; Weckbecker G; Raulf F; Kaupmann K; Schoeffter P; Hoyer D; Lübbert H
Ann N Y Acad Sci; 1994 Sep; 733():138-46. PubMed ID: 7978861
[No Abstract] [Full Text] [Related]
17. 111In-octreotide scintigraphy in metastatic medullary thyroid carcinoma before and after octreotide therapy: in vivo evidence of the possible down-regulation of somatostatin receptors.
Ronga G; Salerno G; Procaccini E; Mauro L; Annovazzi A; Barone R; Mellozzi M; Tamburrano G; Signore A
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):134-6. PubMed ID: 9002772
[TBL] [Abstract][Full Text] [Related]
18. The significance of somatostatin analogues in the antiproliferative treatment of carcinomas.
Kath R; Höffken K
Recent Results Cancer Res; 2000; 153():23-43. PubMed ID: 10626287
[TBL] [Abstract][Full Text] [Related]
19. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
Capello A; Krenning E; Bernard B; Reubi JC; Breeman W; de Jong M
Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1288-95. PubMed ID: 16021448
[TBL] [Abstract][Full Text] [Related]
20. Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancer.
Macaulay VM; Smith IE; Everard MJ; Teale JD; Reubi JC; Millar JL
Br J Cancer; 1991 Sep; 64(3):451-6. PubMed ID: 1654981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
